The modulation of cardiac hypertrophy and fibrosis by ANP is achieved through the activation of several signaling pathways, such as the calcineurin/NFATt, sodium exchanger NHE-1, and TGFβ1/Smad pathways [69]. The gene discussed is NPPA; the disease is cardiac hypertrophy.